Article Listing - Shire's 1st-qtr income soars 85% on sales

NORTH AMERICA'S OTC COUGH COLD MARKET

9 March 1992

By Mick Maroney, manager, North American Region, at Nicholas Hall & Co

The cough and cold remedies market is now established...

CANADA PRIVATIZES DRUG APPROVALS

9 March 1992

In an attempt to speed up the drug marketing approval system, Canada's federal Department of Health and Welfare is now...

NOWEDA FINED BY CARTEL OFFICE

9 March 1992

The German drug wholesaler, Noweda, has been fined 3.1 million Deutschemarks ($1.9 million) by the Federal Cartel Office (BKA) for...

CAL BIO FOURTH QUARTER LOSS

9 March 1992

California Biotechnology of the USA reported a net loss of $17.2 million for the 1991 fiscal year. The loss was...

RECORDATI SHARES EXCHANGE HANDS

9 March 1992

A 1.5% shareholding stake in the Italian pharmaceutical company Recordati changed hands on March 4 on Milan's wholesale bourse, according...

FUJISAWA KOREA JV COMPLETED

9 March 1992

Japan's Fujisawa Pharmaceuticals has revealed that its joint venture plant in South Korea with that country's largest drugmaker, Dong-A Pharmaceuti-cal,...

JAPAN URGES IL-2 AND PKU DRUG APPROVAL

9 March 1992

Japan's Central Pharmaceutical Affairs Council has urged the Public Health and Welfare Ministry to approve for manufacture and sale drugs...

TRIAL GO-AHEAD FOR DEPRENYL'S ALZENE

9 March 1992

Toronto, Canada-based Deprenyl Research Limited has received approval to test the putative anti-Alzheimer's disease drug alzene in humans at medical...

NEW LAB FOR AMERSHAM

9 March 1992

Amersham International reports that it has now extended its contract service for the preparation of radio-labelled biomedical molecules with the...

CAL BIO NAME CHANGE

9 March 1992

The US biotechnology company California Biotechnology has changed its name to Scios Inc. "In anticipation of bringing our pharmaceutical products...